Cargando…
Aptamer selection and applications for breast cancer diagnostics and therapy
Aptamers are short non-coding, single-stranded oligonucleotides (RNA or DNA) developed through Systematic Evolution of Ligands by Exponential enrichment (SELEX) in vitro. Similar to antibodies, aptamers can bind to specific targets with high affinity, and are considered promising therapeutic agents...
Autores principales: | Liu, Mei, Yu, Xiaocheng, Chen, Zhu, Yang, Tong, Yang, Dandan, Liu, Qianqian, Du, Keke, Li, Bo, Wang, Zhifei, Li, Song, Deng, Yan, He, Nongyue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683342/ https://www.ncbi.nlm.nih.gov/pubmed/29132385 http://dx.doi.org/10.1186/s12951-017-0311-4 |
Ejemplares similares
-
An Aptamer-Based Probe for Molecular Subtyping of Breast Cancer
por: Liu, Mei, et al.
Publicado: (2018) -
Point-of-care diagnostics for infectious diseases: From methods to devices
por: Wang, Chao, et al.
Publicado: (2021) -
Applications of Aptamer-Bound Nanomaterials in Cancer Therapy
por: Zhu, Liangxi, et al.
Publicado: (2021) -
The Application of Microfluidic Technologies in Aptamer Selection
por: Liu, Yang, et al.
Publicado: (2021) -
Potential Diagnostic and Therapeutic Applications of Oligonucleotide Aptamers in Breast Cancer
por: Wu, Xiaoqiu, et al.
Publicado: (2017)